Research programme: RNA virus vaccines - Sementis/University of South AustraliaAlternative Names: Chikungunya vaccine - Sementis; SCV 301C; Zika virus vaccine - Sementis
Latest Information Update: 05 Feb 2016
At a glance
- Originator Sementis; University of South Australia
- Class Synthetic vaccines; Viral vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Preclinical Chikungunya virus infections
- Research Zika virus infection